Gonioscopy and Glaucoma

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial

“…Glaucomatous changes in the eye were confirmed by consistent glaucomatous visual field defects that corresponded with characteristic optic disc and retinal nerve fiber layer abnormalities, as assessed by glaucoma specialists [ 27 , 28 ]. Each participant underwent a comprehensive ophthalmologic examination, which included best-corrected visual acuity (BCVA) measured using Snellen chart [ 29 ], intraocular pressure (IOP) assessment via Goldmann applanation tonometry by masked examiners in each institution [ 30 , 31 ], central corneal thickness (CCT) [ 30 , 32 ], gonioscopy [ 33 , 34 ], visual field test with a Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA) [ 35 ], fundus photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], red-free photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], and spectral-domain optical coherence tomography (Carl Zeiss Meditec, Dublin, CA, USA) [ 37 , 38 , 39 ]. Additionally, baseline physical characteristics such as height and weight, were recorded using a standardized stadiometer and digital scale, with participants wearing light clothing and no shoes.…”

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial

“…Glaucomatous changes in the eye were confirmed by consistent glaucomatous visual field defects that corresponded with characteristic optic disc and retinal nerve fiber layer abnormalities, as assessed by glaucoma specialists [ 27 , 28 ]. Each participant underwent a comprehensive ophthalmologic examination, which included best-corrected visual acuity (BCVA) measured using Snellen chart [ 29 ], intraocular pressure (IOP) assessment via Goldmann applanation tonometry by masked examiners in each institution [ 30 , 31 ], central corneal thickness (CCT) [ 30 , 32 ], gonioscopy [ 33 , 34 ], visual field test with a Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA) [ 35 ], fundus photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], red-free photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], and spectral-domain optical coherence tomography (Carl Zeiss Meditec, Dublin, CA, USA) [ 37 , 38 , 39 ]. Additionally, baseline physical characteristics such as height and weight, were recorded using a standardized stadiometer and digital scale, with participants wearing light clothing and no shoes.…”

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial

“…Glaucomatous changes in the eye were confirmed by consistent glaucomatous visual field defects that corresponded with characteristic optic disc and retinal nerve fiber layer abnormalities, as assessed by glaucoma specialists [ 27 , 28 ]. Each participant underwent a comprehensive ophthalmologic examination, which included best-corrected visual acuity (BCVA) measured using Snellen chart [ 29 ], intraocular pressure (IOP) assessment via Goldmann applanation tonometry by masked examiners in each institution [ 30 , 31 ], central corneal thickness (CCT) [ 30 , 32 ], gonioscopy [ 33 , 34 ], visual field test with a Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA) [ 35 ], fundus photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], red-free photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], and spectral-domain optical coherence tomography (Carl Zeiss Meditec, Dublin, CA, USA) [ 37 , 38 , 39 ]. Additionally, baseline physical characteristics such as height and weight, were recorded using a standardized stadiometer and digital scale, with participants wearing light clothing and no shoes.…”

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial

“…Glaucomatous changes in the eye were confirmed by consistent glaucomatous visual field defects that corresponded with characteristic optic disc and retinal nerve fiber layer abnormalities, as assessed by glaucoma specialists [ 27 , 28 ]. Each participant underwent a comprehensive ophthalmologic examination, which included best-corrected visual acuity (BCVA) measured using Snellen chart [ 29 ], intraocular pressure (IOP) assessment via Goldmann applanation tonometry by masked examiners in each institution [ 30 , 31 ], central corneal thickness (CCT) [ 30 , 32 ], gonioscopy [ 33 , 34 ], visual field test with a Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA) [ 35 ], fundus photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], red-free photography (Carl Zeiss Meditec, Dublin, CA, USA) [ 36 ], and spectral-domain optical coherence tomography (Carl Zeiss Meditec, Dublin, CA, USA) [ 37 , 38 , 39 ]. Additionally, baseline physical characteristics such as height and weight, were recorded using a standardized stadiometer and digital scale, with participants wearing light clothing and no shoes.…”